BostonSight’s pilot study, published in Clinical Ophthalmology, explores the use of PROSE scleral lenses as a drug delivery system for cyclosporine 0.05% in treating dry eye disease, showing promising ...
BostonSight’s pilot study, published in Clinical Ophthalmology, explores the use of PROSE scleral lenses as a drug delivery system for cyclosporine 0.05% in treating dry eye disease, showing promising ...
Infants at risk of ROP undergo several fundus examinations that require the use of eyedrops to cause eye dilation, Mataftsi and team noted. "These medications can have serious systemic adverse ...
Opens in a new tab or window Patients with Leber hereditary optic neuropathy (LHON) due to the MT-ND4 gene variant treated with the gene therapy lenadogene nolparvovec in one eye showed a ...
In people older than 55 years who have findings on dilated eye exams that indicate intermediate age-related macular degeneration, a supplement of antioxidants plus zinc may delay progression of ...
Vaidehi S. Dedania, MD, from the New York University (NYU) Langone Health and the Grossman School of Medicine, spoke with the Eye Care Network at this year's AAO meeting held in Chicago, Illinois. She ...
Surgical Innovations in Pediatric Ophthalmology Dr. Stefanie Davidson reviews the highlights from this year's American Association for Pediatric Ophthalmology and Strabismus (AAPOS) meeting.
Roche looks set to mount a challenge to Bayer’s ophthalmology drug Eylea in 2021 after its faricimab antibody showed comparable results in diabetic macular oedema (DME) but with half the ...